New York Life Investment Management LLC Sells 790 Shares of Colgate-Palmolive (NYSE:CL)

New York Life Investment Management LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 121,436 shares of the company’s stock after selling 790 shares during the period. New York Life Investment Management LLC’s holdings in Colgate-Palmolive were worth $11,040,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Robeco Schweiz AG bought a new stake in Colgate-Palmolive in the 4th quarter valued at $2,372,000. Stegent Equity Advisors Inc. raised its stake in shares of Colgate-Palmolive by 23.5% in the 4th quarter. Stegent Equity Advisors Inc. now owns 13,546 shares of the company’s stock valued at $1,231,000 after purchasing an additional 2,579 shares during the period. Whipplewood Advisors LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $66,000. Simmons Bank lifted its holdings in shares of Colgate-Palmolive by 18.3% in the fourth quarter. Simmons Bank now owns 18,768 shares of the company’s stock valued at $1,706,000 after purchasing an additional 2,909 shares in the last quarter. Finally, Checchi Capital Advisers LLC boosted its position in shares of Colgate-Palmolive by 2.1% during the fourth quarter. Checchi Capital Advisers LLC now owns 7,893 shares of the company’s stock worth $718,000 after buying an additional 164 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $90.23 on Friday. The company has a market cap of $73.22 billion, a P/E ratio of 25.63, a P/E/G ratio of 4.20 and a beta of 0.44. The firm’s fifty day moving average price is $88.75 and its two-hundred day moving average price is $95.58. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the company posted $0.87 EPS. Equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.22%. Colgate-Palmolive’s payout ratio is currently 56.82%.

Analyst Upgrades and Downgrades

CL has been the topic of several research reports. UBS Group cut their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Barclays cut their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Finally, StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.